Detalhe da pesquisa
1.
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study.
Ann Oncol
; 31(7): 942-950, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294530
2.
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma.
Ann Oncol
; 30(1): 57-67, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30462163
3.
Human papillomavirus-related oropharyngeal cancer.
Ann Oncol
; 28(10): 2386-2398, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28633362
4.
Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours.
Br J Cancer
; 111(7): 1310-8, 2014 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25077442
5.
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
Ann Oncol
; 25(4): 801-807, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24577117
6.
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).
Ann Oncol
; 25(3): 682-688, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24567516
7.
Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial.
Ann Oncol
; 24(2): 448-453, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23041591
8.
Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.
Br J Cancer
; 104(11): 1691-6, 2011 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21540865
9.
Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines.
Ann Oncol
; 22(10): 2191-200, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21606209
10.
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Ann Oncol
; 22(5): 1078-1087, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21048039
11.
SEOM clinical guidelines for the treatment of head and neck cancer (2020).
Clin Transl Oncol
; 23(5): 913-921, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33635468
12.
The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy.
J Laryngol Otol
; 135(11): 970-975, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482849
13.
Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
Clin Transl Oncol
; 23(9): 1801-1810, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738704
14.
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323).
Br J Cancer
; 103(8): 1173-81, 2010 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20842129
15.
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Ann Oncol
; 21(10): 1967-1973, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20335368
16.
Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
Sci Rep
; 10(1): 13219, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32764593
17.
Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era.
Clin Transl Oncol
; 21(2): 187-196, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948973
18.
Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.
Ann Oncol
; 19(1): 142-9, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17785763
19.
Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy.
Cancer Radiother
; 12(2): 88-95, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18155633
20.
Comments on "Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines".
ESMO Open
; 8(3): 101212, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054478